Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial
R Erbel,
T Pop,
KJ Henrichs,
K von Olshausen,
CJ Schuster,
HJ Rupprecht,
C Steuernagel,
and
J Meyer
In 162 patients with acute transmural myocardial infarction, combined intravenous and intracoronary thrombolytic therapy with streptokinase was initiated. In vessels that remained occluded, mechanical recanalization was performed with a 3F recanalization catheter (group I, n = 79) or a 4F Gruntzig balloon catheter (group II, n = 83). After reperfusion, intracoronary streptokinase was administered superselectively. After termination of streptokinase infusion, angioplasty was performed only in patients in group II. There was no difference between the groups in relation to sex, age, infarct location, creatine kinase levels and time between onset of symptoms and start of treatment. Initial coronary angiography showed an open vessel in 27 (34%) of 79 patients in group I and 21 (25%) of 83 patients in group II. The final reperfusion rate was 90% (71 of 79) in group I and 86% (71 of 83) in group II. Angioplasty was attempted in 69 of the 71 patients in group II with a success rate of 65% and an occlusion rate of 3%. During the hospital stay, reocclusion occurred in 14 (20%) of 71 patients in group I. After thrombolytic therapy, coronary luminal narrowing in group I was 75 +/- 17% in patients without and 87 +/- 6% in patients with reocclusion (p less than 0.05). In group II, reocclusion was found in 10 (14%) of 71 patients. After angioplasty, the degree of coronary stenosis in group II was reduced from 82 +/- 12 to 51 +/- 30% (p less than 0.001). Reocclusion was found in 3 (7%) of the 45 patients with successful angioplasty and in 7 (32%) of the 22 patients with unsuccessful angioplasty (p less than 0.01). Improvement in regional left ventricular function was observed only in patients from group II with anterior myocardial infarction. In conclusion, by combined medical and mechanical recanalization, the rate of coronary reperfusion can be increased and infarct time shortened, providing the possibility of full revascularization by angioplasty, with improvement of regional wall motion and reduction of the rate of reocclusion.
This article has been cited by other articles:

|
 |

|
 |
 
P. Widimsky, L. Groch, M. Zelizko, M. Aschermann, F. Bednar, and H. Suryapranata
Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study
Eur. Heart J.,
May 2, 2000;
21(10):
823 - 831.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schlensak, T. Doenst, J. Kobba, and F. Beyersdorf
Protection of acutely ischemic myocardium by controlled reperfusion
Ann. Thorac. Surg.,
November 1, 1999;
68(5):
1967 - 1970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Brodison, R. S More, and A. Chauhan
Stents in medicine: The role of coronary angioplasty and stenting in acute myocardial infarction
Postgrad. Med. J.,
October 1, 1999;
75(888):
591 - 598.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. J. Scanlon, D. P. Faxon, A.-M. Audet, B. Carabello, G. J. Dehmer, K. A. Eagle, R. D. Legako, D. F. Leon, J. A. Murray, S. E. Nissen, et al.
ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions
J. Am. Coll. Cardiol.,
May 1, 1999;
33(6):
1756 - 1824.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Beyersdorf
Protection of Evolving Myocardial Infarction and Failed PTCA
Ann. Thorac. Surg.,
September 1, 1995;
60(3):
833 - 838.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Bauters, P. Khanoyan, E. P. Mc Fadden, P. Quandalle, J.-M. Lablanche, and M. E. Bertrand
Restenosis After Delayed Coronary Angioplasty of the Culprit Vessel in Patients With a Recent Myocardial Infarction Treated by Thrombolysis
Circulation,
March 1, 1995;
91(5):
1410 - 1418.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. B. Michels and S. Yusuf
Does PTCA in Acute Myocardial Infarction Affect Mortality and Reinfarction Rates? : A Quantitative Overview (Meta-Analysis) of the Randomized Clinical Trials
Circulation,
January 15, 1995;
91(2):
476 - 485.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. J. Topol, D. R. Holmes, and W. J. Rogers
Coronary Angiography after Thrombolytic Therapy for Acute Myocardial Infarction
Ann Intern Med,
May 15, 1991;
114(10):
877 - 885.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Naylor and S. B. Jaglal
Impact of Intravenous Thrombolysis on Short-term Coronary Revascularization Rates: A Meta-analysis
JAMA,
August 8, 1990;
264(6):
697 - 702.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. W. Rowe, R. J. Simpson Jr, D. A. Tate, P. W. Willis IV, T. C. Nichols, J. W. Noneman, and L. S. Gettes
Nonemergent Cardiac Catheterization and Risk-Stratified Revascularization Following Thrombolytic Therapy for Acute Myocardial Infarction: A Critical Analysis of Therapy in the Community Setting
Arch Intern Med,
July 1, 1989;
149(7):
1611 - 1617.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Topol
Coronary Angioplasty for Acute Myocardial Infarction
Ann Intern Med,
December 15, 1988;
109(12):
970 - 980.
[Abstract]
[PDF]
|
 |
|
|